Cure Leukaemia become the official charity partner of Le Tour de France Femmes avec Zwift

Cure Leukaemia will be adding the Tour de France Femmes avec Zwift (TDFFAZ) event to their portfolio of cycling events.
The Route” will offer an all-female team of cyclists the opportunity to complete all eight stages of the 2024 Tour de France Femmes avec Zwift.
National Blood Cancer Charity Cure Leukaemia are the first official Charity Partner of the Tour de France in the UK and have extended their relationship with the event until 2026.

Cure Leukaemia and raise funds with the Tour de France Femmes avec Zwift

National blood cancer charity Cure Leukaemia has strengthened their relationship with one of the most iconic cycling events in the world by becoming the first ever Official Charity Partner of the Tour de France Femmes avec Zwift (TDFFAZ) in the UK.
As part of the partnership, the charity have today launched ‘The Route’ which will see up to 25 amateur cyclists ride the full TDFFAZ route in 2024, one day ahead of the professional race.
First announced in 2021, the first Tour de France Femmes avec Zwift launched the following year with immense success and demonstrated the significant growth and demand for female cycling events across the world. The landmark race featured eight stages of racing with a similar number of stages planned for the 2023 and 2024 editions, with ambitious plans to expand the race over the coming years. The inaugural edition saw the pro’s tackle 1,033km across the eight consecutive days.
Sitting alongside the charity’s flagship event - The Tour 21 - “The Route” will be organised by Cure Leukaemia and will offer female riders the opportunity to live the Route, feel the Route and ride the Route - staying in the same hotels as the pros, receive official training and event kit from the charity’s official kit supplier, Santini, dedicated physio and mechanical support along the way and rolling road closures throughout the event – topped off with a 5* finish to celebrate.